Open the mobile version, with barcode scanning
Class III Terminated

FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.

Why: CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.

Company
Boehringer Ingelheim Roxane Inc
Columbus, OH, United States
Reported
Oct 21, 2015
Recall started
Sep 25, 2015
Ended
Feb 19, 2016
Where sold
Nationwide and Puerto Rico
Amount
11,110 bottles
Full product description
FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.
Lots / codes affected
Lot #: 559660P, 559661P, Exp 03/17

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.